The State of CX for the Pharmaceutical Industry
We surveyed 200 C-suite executives across the United States to understand how they’re navigating today’s challenges—and what strategies they’re using to not just weather the disruption, but actively transform their people, processes, and technologies. Ultimately, we wanted to learn how they plan to stay relevant, grow market share, and remain competitive in a rapidly evolving landscape.
What you’ll get from this report:
- Gain a strong understanding of how and where companies are implementing AI.
- See what challenges companies are experiencing with AI adoption – and see how you could avoid similar pitfalls.
- Understand how AI is restructuring organizations and job roles – and how they are managing this change.
- Understand how businesses are implementing ‘reskilling’ and ‘upskilling’ within their organization and the issues they are facing.
- See how and why many companies are retooling their onboarding and new hire training programs to stay competitive.
- Get a first-hand look at the threat of the “Peak 65” wave that is hitting now and into 2027.
The Northridge Group needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.
Helping pharmaceutical companies for over 20 years
In 2025, U.S. pharmaceutical companies face intense pressure to innovate while containing costs and meeting strict regulatory standards.
Workforce shortages and “Peak 65” retirements are straining both R&D and manufacturing talent pipelines. AI is creating breakthroughs in discovery and patient engagement, yet adoption is slowed by legacy systems and compliance risks.
Meanwhile, patients and providers demand faster, more transparent, and more affordable access to therapies.
The industry’s future depends on balancing cost efficiency, workforce transformation, regulatory compliance, and AI-driven innovation.
